Results 1 to 10 of about 19,123 (184)

Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers

open access: yesFrontiers in Cell and Developmental Biology, 2022
Aptamers are short single-strand oligonucleotides that can form secondary and tertiary structures, fitting targets with high affinity and specificity.
Yongshu Li   +13 more
doaj   +3 more sources

Probing three-dimensional cyclooctatetraene for nucleobase modification in aptamer selection [PDF]

open access: yesCommunications Chemistry
Decoration of aptamers with chemical modifications at the level of nucleobases grants access to alternative binding modes, which often result in improved binding properties.
Greta Charlotte Dahm   +9 more
doaj   +2 more sources

Sequence optimization of a DNA aptamer inhibiting COVID-19 infection guided by analysis of secondary structure distribution [PDF]

open access: yesComputational and Structural Biotechnology Journal
The post-SELEX optimization of nucleic acid aptamers is often hindered by conformational ambiguity, as the specific functional structure is typically unknown.
Maria Izabel Muniz   +10 more
doaj   +2 more sources

The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer’s Disease [PDF]

open access: yesCells
Alzheimer’s disease (AD) is the neurodegenerative condition with the outmost future challenges, with timely diagnosis and treatment being the most urgent.
Georgios Katsipis   +3 more
doaj   +2 more sources

The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing -(1 -pentynyl)-2′-deoxyuridine [PDF]

open access: yesNucleic Acids Research, 1994
Combinatorial libraries of nucleic acids are developing into novel sources for lead compounds in drug development. In order to diversify the pool of ss DNA sequences, we have used a modified nucleotide, 5-(1-pentynyl)-2'-deoxyuridine, in place of thymidine in a random nucleic acid library and screened this library against human thrombin. Previously, we
John A. Latham   +2 more
openaire   +2 more sources

Nucleotide Bias Observed with a Short SELEX RNA Aptamer Library [PDF]

open access: yesNucleic Acid Therapeutics, 2011
Systematic evolution of ligands by exponential enrichment (SELEX) is a powerful in vitro selection process used for over 2 decades to identify oligonucleotide sequences (aptamers) with desired properties (usually high affinity for a protein target) from randomized nucleic acid libraries.
William H, Thiel   +12 more
openaire   +2 more sources

Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding

open access: yesViruses, 2021
The causative agent of COVID-19, SARS-CoV-2, gains access to cells through interactions of the receptor-binding domain (RBD) on the viral S protein with angiotensin-converting enzyme 2 (ACE2) on the surface of human host cells.
Irani Alves Ferreira-Bravo   +1 more
doaj   +1 more source

PPAI: a web server for predicting protein-aptamer interactions

open access: yesBMC Bioinformatics, 2020
Background The interactions between proteins and aptamers are prevalent in organisms and play an important role in various life activities. Thanks to the rapid accumulation of protein-aptamer interaction data, it is necessary and feasible to construct an
Jianwei Li   +3 more
doaj   +1 more source

DNA aptamer against EV-A71 VP1 protein: selection and application

open access: yesVirology Journal, 2021
Background Enterovirus 71 (EV-A71) is a highly infectious pathogen associated with hand, foot and mouth disease, herpangina, and various neurological complications, so it is important for the early detection and treatment of EV-A71.
Xinran Zou   +4 more
doaj   +1 more source

Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach

open access: yesMolecules, 2022
Aptamers, the nucleic acid analogs of antibodies, bind to their target molecules with remarkable specificity and sensitivity, making them promising diagnostic and therapeutic tools. The systematic evolution of ligands by exponential enrichment (SELEX) is
Ashraf M. Muhammad   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy